COMBINATION OF NITRIC OXIDE, HELIUM AND ANTIBIOTIC TO TREAT BACTERIAL LUNG INFECTIONS

• 1. 采用一氧化氮清除剂的联合治疗方法 [P] . 中国专利： CN1202824A . 1998-12-23
• 2. 一氧化氮气与氦气协同治疗呼吸类重症疾病的气体药物 [P] . 中国专利： CN106581047A . 2017-04-26
• 3. COMBINATION OF NITRIC OXIDE, HELIUM AND ANTIBIOTIC TO TREAT BACTERIAL LUNG INFECTIONS [P] . 美国专利： US2018264032A1 . 2018-09-20

  机译： 一氧化氮，氦气和抗生素联合治疗细菌性肺部感染

• 4. COMBINATION OF NITRIC OXIDE, HELIUM AND ANTIBIOTIC TO TREAT BACTERIAL LUNG INFECTIONS [P] . 世界知识产权组织专利： WO2016124723A1 . 2016-08-11

  机译： 一氧化氮，氦气和抗生素联合治疗细菌性肺部感染

• 5. Combination of nitric oxide, helium and antibiotic to treat bacterial lung infections [P] . 欧洲知识产权局专利： EP3053587A1 . 2016-08-10

  机译： 一氧化氮，氦气和抗生素的组合治疗细菌性肺部感染

• 1. Effects of glucocorticoid dexamethasone on serum nitric oxide synthase activity and nitric oxide levels in a rat model of lung disease-induced brain injury [J] . Huajun Li, Ligang Jiang, Meng Xia, 中国神经再生研究：英文版 . 2011,第025期
• 2. Effects of glucocorticoid dexamethasone on serum nitric oxide synthase activity and nitric oxide levels in a rat model of lung disease-induced brain injury [J] . Huajun Li, Ligang Jiang, Meng Xia, 中国神经再生研究（英文版） . 2011,第025期
• 3. Effects of aerosolized ketamine on the level of nitric oxide and nitric oxide synthetase in the lung tissue of rat with asthma [J] . 生物医学研究杂志（英文版） . 2006,第002期
• 4. Gaseous nitric oxide to treat antibiotic resistant bacterial and fungal lung infections in patients with cystic fibrosis: a phase I clinical study [J] . Deppisch Caroline, Herrmann Gloria, Graepler-Mainka Ute, Infection . 2016,第4期
• 5. Effects of the antibiotic component on in-vitro bacterial killing, physico-chemical properties, aerosolization and dissolution of a ternary-combinational inhalation powder formulation of antibiotics for pan-drug resistant Gram-negative lung infections [J] . Mangal Sharad, Huang Jiayang, Shetty Nivedita, International Journal of Pharmaceutics . 2019,第期
• 6. Peptide IDR-1018: modulating the immune system and targeting bacterial biofilms to treat antibiotic-resistant bacterial infections [J] . Mansour Sarah C., de la Fuente-Nunez Cesar, Hancock Robert E. W. Journal of peptide science: An official publication of the European Peptide Society . 2015,第5期
• 7. Phage therapy: an innovative approach to treat antibiotic-resistant bacterial infections [C] . Kishore Murthy, Beatrice Allain, Jean-Louis Roman, Annual Meeting of the American Association of Swine Veterinarians . 2002
• 8. Exploring Antibiotic and Innate Immune Synergies to Treat Multi-Drug Resistant Bacterial Infections [D] . Lin, Leo. 2016
• 9. Successfully Treated Escherichia coli-Induced Emphysematous Cyst Infection with Combination of Intravenous Antibiotics and Intracystic Antibiotics Irrigation in a Patient with Autosomal Dominant Polycystic Kidney Disease [O] . Hyunsuk Kim, Hayne Cho Park, Sunhwa Lee, 2013
• 10. Effects of the antibiotic component on in-vitro bacterial killing, physico-chemical properties, aerosolization and dissolution of a ternary-combinational inhalation powder formulation of antibiotics for pan-drug resistant Gram-negative lung infections [O] . Sharad Mangal, Jiayang Huang, Nivedita Shetty, 2019

• 1. Effect of Helicobacterpyloriinfection on gastric mucosal pathologic change and level of nitric oxide and nitric oxide synthase [J] . Yong-Fu Wang Chun-Lin Guo Li-Zhen Zhao Guo-An Yang Peng Chen Hong-Kun Wang . 世界胃肠病学杂志：英文版 . 2005,第32期
• 2. BACKGROUND： Vibrio vulnifi cus inside the body could activate the NF-!B signaling pathwayand initiate the inflammatory cascade. The lung is one of the earliest organs affected by sepsisassociated with acute lung injury. High mobility group protein B1 （HMGB1） is an important late-actingpro-infl ammatory cytokine involving in the pathophysiology of sepsis. It is also involved in the injuryprocess in the lung, liver and intestine. There has been no report on the involvement of HMGB1 inVibrio vulnifi cus sepsis-induced lung injury.METHODS： Sixty rats were randomly divided into a normal control group （group A, n=10） anda Vibrio vulnificus sepsis group （group B, n=50）. Sepsis was induced in the rats by subcutaneousinjection of Vibrio vulnificus （concentration 6×108 cfu/mL, volume 0.1 mL/100g）） into the left lowerlimbs. The rats in group B were sacrifi ced separately 1, 6, 12, 24, and 48 hours after the infection.Their lungs were stored as specimens, lung water content was measured, and lung pathology wasobserved under a light microscope. The expressions of the HMGB1 gene and protein in the lungswere detected by RT-PCR and Western blot. Data were analyzed with one-way analysis of variance（ANOVA） and the LSD method for pair-wise comparison between the two groups. P〈0.05 wasconsidered statistically signifi cant.RESULTS： Compared to group A （0.652±0.177）, HMGB1 mRNA expression in the lungs ofgroup B was signifi cantly higher at 0 hour （1.161±0.358, P=0.013）, 24 hours （1.679±0.235, P=0.000）,and 48 hours （1.258±0.274, P=0.004） （P〈0.05）, and peaked at 24 hours. Compared to group A（0.594±0.190）, HMGB1 protein expression at 6 hours （1.408±0.567, P=0.026） after infection wassignificantly increased （P〈0. 05）, and peaked at 24 hours （2.415±1.064, P=0.000） after infection.Compared to group A （0.699±0.054）, lung water content was significantly increased at 6 hours（0.759±0.030, P=0.001）,12 hours （0.767±0.023, P=0.000）, 24 hours （0.771±0.043, P=0.000） and 48hours （0.789±0.137, P=0.000） after infection （P〈0.05）. Compared to group A, pathological changesat 12 hours in group B indicate marked pulmonary vascular congestion, interstitial edema andinfl ammatory infi ltration. Alveolar cavity collapse and boundaries of the alveolar septum could not beclearly identifi ed.CONCLUSION： Vibrio vulnifi cus sepsis can lead to injury in rat lungs, and increased HMGB1expression in lung tissue may be one of the mechanisms for injury from Vibrio vulnifi cus sepsis. [J] . Qiao-meng Qiu ,Zhong-wang Li ,Lu-ming Tang . 世界急诊医学杂志(英文) . 2011,第4期
• 3. 痰培养对长期留置气管切开导管病人细菌性肺部感染的诊断意义探讨 [C] . 周信杰 . 2016粤湘赣康复医学论坛 . 2016
• 4. 龙胆泻肝汤与甲硝唑联合治疗细菌性阴道病疗效观察 [A] . 杨雨曼 . 2013